T2 Biosystems Inc Стоимость предприятия

Что обозначает Стоимость предприятия в T2 Biosystems Inc?

Стоимость предприятия T2 Biosystems Inc является $76.25M

Какое определение для Стоимость предприятия?



Стоимость предприятия является измерением общей рыночной стоимости компании. Она рассчитывается как рыночная капитализация с учётом долга, доли меньшинства и привилегированных акций за вычетом общей суммы денежных средств и их эквивалентов.

It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.

Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.

Стоимость предприятия компаний в Health Care сектор на NASDAQ по сравнению с T2 Biosystems Inc

Что делает T2 Biosystems Inc?

t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www

Компании с стоимость предприятия похож на T2 Biosystems Inc



  • Titan Mining имеет Стоимость предприятия из $75.95M
  • Image Resources NL имеет Стоимость предприятия из $76.04M
  • Gordon Pointe Acquisition имеет Стоимость предприятия из $76.04M
  • Wanda Hotel Development имеет Стоимость предприятия из $76.05M
  • Commercial Syn Bags имеет Стоимость предприятия из $76.05M
  • Blue имеет Стоимость предприятия из $76.17M
  • T2 Biosystems Inc имеет Стоимость предприятия из $76.25M
  • Urja Global имеет Стоимость предприятия из $76.25M
  • Fluence имеет Стоимость предприятия из $76.31M
  • ATTRAQT plc имеет Стоимость предприятия из $76.32M
  • Bragg Gaming имеет Стоимость предприятия из $76.38M
  • Great Panther Mining имеет Стоимость предприятия из $76.41M
  • Anaconda Mining имеет Стоимость предприятия из $76.42M